Ubrogepant
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 200 publications
Focus on migraine prodrome: what should clinicians know?
Journal: Current opinion in neurology
Published: April 09, 2026
Migrainous Thoracalgia in a Patient with Chronic Migraine and Coronary Vasospasm: A Case Report.
Journal: International medical case reports journal
Published: January 30, 2026
Ubrogepant Plasma and Cerebrospinal Fluid Exposures in Participants With a History of Migraine: Findings From a Phase 1b Open-Label Trial.
Journal: Clinical and translational science
Published: January 02, 2026
Population Pharmacokinetics and Exposure-Response Analyses for Ubrogepant Efficacy and Safety in the Acute Treatment of Migraine: Analysis of Phase 1-3 Studies.
Journal: Journal of clinical pharmacology
Published: December 16, 2025
Identifying cardiac safety signals of disproportionate reporting for CGRP antagonists: evidence from the FDA Adverse Event Reporting System.
Journal: Naunyn-Schmiedeberg's archives of pharmacology
Published: December 09, 2025
Efficacy, safety, and tolerability of ubrogepant in the treatment of acute migraine among migraine patients in Hail City, Saudi Arabia: A retrospective case.
Journal: Journal of family medicine and primary care
Published: December 04, 2025
Cost-effectiveness analysis of ubrogepant, rimegepant, and zavegepant for acute migraine treatment vs usual care.
Journal: The American journal of managed care
Published: November 25, 2025
Early Experience Treating Vestibular Migraine With Small Molecule CGRP Antagonists.
Journal: Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
Published: October 22, 2025
Last Updated: 09/26/2026